Summary of Trading Off The Bottom - January 8.
At
Summary of Trading Off The Bottom - January 8.
At .0002:
December 8: 3M
December 11: 6M
December 12: 3M
December 13: 10M
December 14: 52M
December 15: 14M
December 18: 19M
December 19: 14M
December 20: 22M
December 21: 18M
December 22: 7M
December 26: 34M
December 27: 24M
December 28: 24M
December 29: 43M
January 2: 17M
January 3: 13M
January 4: 9M
January 5: 3M
January 8: 12M
Total: 347M
At .0001:
December 7: 415M [260M bought on bid / 155M bought on ask].
December 8: 366M
December 11: 8M
December 12: 219M
December 13: 22M
December 14: 25M
December 15: 1M
December 19: 3M
December 20: 19M
December 21: 6M
December 22: 3M
December 23: 2M
December 28: 10M
December 29: 5M
January 2: 2M
January 3: 12M
January 4: 9M
January 5: 2M
January 8: 20M
Total 920M
In addition the following quantities of .0001s may be in the hands of retail investors if not sold even on December 7:
November 29: 4M
December 5: 170M
December 6: 113M
Total: 287M
Discounting late print of 90M + 82,540,103 at .00098 Form T on December 12 which did not got to retail.
Discounting late print of 4 x 90M + 80.699.580M at .000098 Form T on December 7 which did not go to retail.
Discounting assumed mirror trades of 4 x 90M + 20,000,200 at .000098 then at .0001 on December 5. Might need to assume later that 380M or 760M acquired at .0001 - will become evident when .0002s and .0003s bought out.
Discounting assumed mirror trades of 2 x 90M + 56,499,900 at .0001 then .000098 on November 29. Might need to assume later that 236M or 472M acquired at .0001 - will become evident when .0002s and .0003s bought out.
Tersis Technologies, Inc. (TERS) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding the Data Diode Solutions Market The Data Diode Solutions Market is rapidly evolving, with significant growth observed over recent years. This market is projected to increase from its current valuation of millions to an anticipated valuation surpassing USD 1.29 billion by the year 2033. This upward trajectory is driven by a compound annual growth rate (CAGR)...
Continue Reading
D.R. Horton Surpasses Revenue and Profit Expectations D.R. Horton has recently reported remarkable first-quarter results that exceeded analysts' expectations for both revenue and profit. This achievement comes in the context of a continuous shortage of existing homes in the U.S. housing market, which has significantly boosted the demand for new home sales, even amidst...
Continue Reading
Introduction to the MS Mitsui Ocean Fuji The cruise industry is evolving, and the MS Mitsui Ocean Fuji, a remarkable vessel, is at the forefront of this change. This Japanese cruise ship, operated by Mitsui O.S.K. Lines, is an impressive example of how modern technology can meet sustainable practices in marine operations. History and Transition of the Ship Originally...
Continue Reading
South Korea's Trade Deal Approaches Negotiation Hurdles In the world of international trade, negotiations can swing between promise and peril. Recently, the South Korean President Lee Jae Myung has raised significant concerns regarding a proposed trade deal with the United States, valued at $350 billion. This deal, originally discussed with former President Donald Trump,...
Continue Reading
Cullinan Therapeutics' New Milestone in Cancer Treatment Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, has recently received a significant boost in its fight against acute myeloid leukemia (AML). The U.S. Food and Drug Administration (FDA) has awarded Fast Track designation to its investigational drug CLN-049. This crucial milestone allows for...
Continue Reading